MedTrace Logo

Regulation and Mechanism of New Compound Functional Ingredients in Infants

NCT05297006 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2022-03-25

No results posted yet for this study

Summary

A prospective, multicentre, randomized, double-blind, parallel control study was conducted to analyze the changes in growth, intestinal flora, and immune function of infants with different feeding patterns from postnatal to 1 year of age.

Conditions

  • Sialic Acid
  • Oligosaccharide

Interventions

DIETARY_SUPPLEMENT

The infants who drank milk powder were given a dietary intervention four months before

The infants who eat milk powder were randomly divided into two groups: group containing new compound functional ingredients and group without new compound functional ingredients

Sponsors & Collaborators

  • Peking University First Hospital

    collaborator OTHER

  • Peking University People's Hospital

    collaborator OTHER

  • Peking University Third Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2022-10-31
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05297006 on ClinicalTrials.gov